Pregled bibliografske jedinice broj: 1119192
Circulating Her-2/Neu Extracellular Domain in Breast Cancer Patients-Correlation with Prognosis and Clinicopathological Parameters Including Steroid Receptor, Her-2/Neu Receptor Coexpression
Circulating Her-2/Neu Extracellular Domain in Breast Cancer Patients-Correlation with Prognosis and Clinicopathological Parameters Including Steroid Receptor, Her-2/Neu Receptor Coexpression // Pathology & Oncology Research, 21 (2014), 3; 589-595 doi:10.1007/s12253-014-9859-6 (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 1119192 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Circulating Her-2/Neu Extracellular Domain in
Breast Cancer Patients-Correlation with
Prognosis and Clinicopathological Parameters
Including Steroid Receptor, Her-2/Neu Receptor
Coexpression
Autori
Barić, Marina ; Kulić, Ana ; Sirotković- Skerlev, Maja ; Dedić Plavetić, Natalija ; Vidović, Marina ; Horvatić-Herceg, Gordana ; Vrbanec, Damir
Izvornik
Pathology & Oncology Research (1219-4956) 21
(2014), 3;
589-595
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
HER-2/neu ECD ; Breast cancer ; Prognosis ; Steroid receptor/HER-2/neu receptor coexpression
Sažetak
HER-2/neu extracellular domain (ECD) can be detected in blood as a soluble circulating protein. The aim of this study was to analyze the relationship between HER-2/neu extracellular domain in the serum and the prognosis in breast cancer patients. We also correlated HER-2/neu ECD with various clinicopathological factors including steroid receptor, HER-2/neu receptor coexpression. The serum from seventy nine patients with invasive breast cancer and twenty individuals without malignancy was analyzed using the enzyme-linked immune adsorbent assay method. The cut-off value was estimated by the ROC curve analysis (15.86 mu g/L). HER-2/neu ECD values in the serum of patients with breast cancer were significantly higher than in control subjects. Circulating HER-2/neu ECD was significantly associated with the histological grade of tumors and the status of axillary lymph nodes. Negative correlation was observed between HER- 2/neu ECD in the serum and estrogen receptor positivity. When we analyzed HER-2/neu ECD in relation with coexpression of steroid receptor and HER-2/neu receptor in tissue, statistically higher values were found in the subgroup of patients with steroid receptor negative, HER- 2/neu negative tumors than in the other subgroups. HER-2/neu ECD was not an independent factor in the univariate and multivariate analysis. However, elevated HER-2/neu ECD levels were found in patients with breast cancer possessing more aggressive phenotype.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
POVEZANOST RADA
Ustanove:
Medicinski fakultet, Zagreb,
Klinički bolnički centar Zagreb
Profili:
Marina Popović
(autor)
Gordana Horvatić Herceg
(autor)
Damir Vrbanec
(autor)
Natalija Dedić-Plavetić
(autor)
Ana Kulić
(autor)
Maja Sirotković-Skerlev
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE